These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin. Le TD; Yamada SD; Rutgers JL; DiSaia PJ Gynecol Oncol; 1999 Jun; 73(3):461-3. PubMed ID: 10366480 [TBL] [Abstract][Full Text] [Related]
5. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma. Zanotti KM; Belinson JL; Kennedy AW; Webster KD; Markman M Gynecol Oncol; 1999 Aug; 74(2):272-7. PubMed ID: 10419744 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma. Low JS; Wong EH; Tan HS; Yap SP; Chua EJ; Sethi VK; Soh LT; Low J; Tay EH; Chew SH Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Zanetta G; Fei F; Mangioni C Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. Bamias A; Deliveliotis Ch; Fountzilas G; Gika D; Anagnostopoulos A; Zorzou MP; Kastritis E; Constantinides C; Kosmidis P; Dimopoulos MA J Clin Oncol; 2004 Jun; 22(11):2150-4. PubMed ID: 15169801 [TBL] [Abstract][Full Text] [Related]
11. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948 [TBL] [Abstract][Full Text] [Related]
12. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947 [TBL] [Abstract][Full Text] [Related]
13. The role of optimal debulking in advanced stage serous carcinoma of the uterus. Moller KA; Gehrig PA; Van Le L; Secord AA; Schorge J Gynecol Oncol; 2004 Jul; 94(1):170-4. PubMed ID: 15262137 [TBL] [Abstract][Full Text] [Related]
14. Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience. Hoskins PJ; Le N; Ellard S; Lee U; Martin LA; Swenerton KD; Tinker AV; Gynecol Oncol; 2008 Jan; 108(1):58-62. PubMed ID: 17935761 [TBL] [Abstract][Full Text] [Related]
15. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin. Takekuma M; Hirashima Y; Takahashi N; Yamamichi G; Furukawa N; Yamada Y; Takakuwa R; Ito I Anticancer Drugs; 2006 Jul; 17(6):715-8. PubMed ID: 16917218 [TBL] [Abstract][Full Text] [Related]
16. Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC). Fields AL; Einstein MH; Novetsky AP; Gebb J; Goldberg GL Gynecol Oncol; 2008 Jan; 108(1):201-6. PubMed ID: 17997145 [TBL] [Abstract][Full Text] [Related]
17. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; VillĂ S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A; Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209 [TBL] [Abstract][Full Text] [Related]